Puffer Sales

Dent headache had all of their doctors enrolled as clinical trial investigators then after the drug is approved all became paid speakers

They're getting paid to write

 

Why else would they go through the trouble with this ridiculous contraption?
Unless they are filling the puffer with some other substance?

 

The Puffer feedback has gotten very quiet

 

Man, there are some real morons commenting here and showing their ignorance about migraine, maybe that's why your numbers suck. It's a good product and there's a need for it but it's a Triptan not a cure for cancer. Also, if your manager is asking why you can't sell like the Buffalo rep, they're a moron too. Buffalo has the DENT clinic and it's a migraine factory. Not a difficult sell there if you have a migraine drug.

 

What are your numbers tough guy?
Dont include freebies!

 

We were told to wink when the doctor asks about improved efficacy?

Or just say "Uh-huh"

 

Absolutely not true. Maybe in your sad world. If kols and ad board people were doing anything we wouldn't have had that meeting in dallas. there are a number of reps that have no kol, no speaker, no ad board and horrible coverage and are doing amazing. you just suck. go to another company so you can pop up on their board 2 months later to say how awful it is.

 

Agreed! So over the whiners!

 

Great comments from our Marketing team on why we can sell without KOLs and speakers, right!

 

No doctor in his right mind would prescribe this without being paid, it has no data!

 

$3.4M in net sales last quarter? We have to stop this.

 

Is that good?
3.4 mill for puffer in Q4 ?

 

Is that good?
3.4 mill for puffer in Q4 ?

 

That's horrible! Considering the cost of marketing and the sales force, the company is lucky to break even. Just to give some perspective, before Imitrex went generic, it produced over a billion per year in sales.

 

But it's a pill , not a puffer and
It was a 1st line medication, not
A 3rd line and out puffer is not
Even covered on United Health Care
One of the largest plans in the USA

 

Whatever makes you feel better. I was just trying to give you some perspective on what level of revenue "successful" migraine products produce. By the way, almost every product is covered on UHC when they first launch.

 

and now a major price increase on a generic product

 

Stick to what you know Mr. wanna be stock analyst.

Comparing a "new" product to Imitrex is what got this company in over their head with this one. This falls into the extended release or modified delivery category, which rarely if ever does as well as the innovator molecule. As for UHC, they seldom cover products of this nature as they can push generics more cheaply and you have no data to counter that decision.

 

Wrong!
Wrong!
Wrong!
Wrong!

 

sounds like Mylan !!!!